[Effects of combined chemotherapy and radiotherapy on the hypothalamo-pituitary-gonadal axis and adrenocortical function in male patients with urogenital cancer].
D000302:Adrenal Cortex / Q000503:physiopathology*; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D000328:Adult; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology*; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010902:Pituitary Gland / Q000503:physiopathology*; D013737:Testis / Q000503:physiopathology*; D014565:Urogenital Neoplasms / Q000503:physiopathology / Q000628:therapy*
D000324:Adrenocorticotropic Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone